abstract |
Inhibitors of the cytosolic phospholypase A2 enzymes are provided which are of use in controlling a wide variety of inflammatory diseases. The inhibitors of the present invention have the general formula n where X, Z, X 1 , R 1 , R 2 , R a and R b are as defined in the specification. |